ramatroban has been researched along with leukotriene b4 in 1 studies
Studies (ramatroban) | Trials (ramatroban) | Recent Studies (post-2010) (ramatroban) | Studies (leukotriene b4) | Trials (leukotriene b4) | Recent Studies (post-2010) (leukotriene b4) |
---|---|---|---|---|---|
142 | 10 | 28 | 5,886 | 232 | 717 |
Protein | Taxonomy | ramatroban (IC50) | leukotriene b4 (IC50) |
---|---|---|---|
Leukotriene B4 receptor 1 | Homo sapiens (human) | 0.0019 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bacon, KB; Gantner, F; Nagao, K; Shichijo, M; Sugimoto, H; Takeshita, K; Yamasaki, T | 1 |
1 other study(ies) available for ramatroban and leukotriene b4
Article | Year |
---|---|
CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation.
Topics: Animals; Carbazoles; Chemokine CXCL1; Chemokines; Chemokines, CXC; Cytokines; Dermatitis, Allergic Contact; Dermatitis, Atopic; Eosinophils; Female; Inflammation; Leukotriene B4; Mice; Mice, Inbred BALB C; Neutrophil Activation; Neutrophils; Platelet Aggregation Inhibitors; Prostaglandin D2; Receptors, Immunologic; Receptors, Prostaglandin; Signal Transduction; Sulfonamides; Th2 Cells | 2004 |